berberine has been researched along with Atheroma in 7 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study aims to analyze the effect of berberine on serum inflammatory factors and carotid atherosclerotic plaques in ppatients with acute cerebral ischemic stroke(AIS)." | 9.22 | [Effects of berberine on serum inflammatory factors and carotid atherosclerotic plaques in patients with acute cerebral ischemic stroke]. ( Chai, MJ; Li, HS; Li, Y; Lu, DD; Wang, H; Wang, P; Yang, F; Zhao, J, 2016) |
| "Berberine (BBR) is an effective component of Huanglian and has shown to attenuate atherosclerosis (AS); however, the detailed mechanism of BBR-mediated protective actions against AS remains elusive." | 7.96 | Berberine Attenuates Arterial Plaque Formation in Atherosclerotic Rats with Damp-Heat Syndrome via Regulating Autophagy. ( Huang, Y; Ke, X; Li, L; Lin, F; Song, Y; Xin, F; Xu, L; Zeng, Z; Zhang, Y, 2020) |
| " Berberine is used to treat obesity, diabetes and atherosclerosis." | 7.88 | Berberine treatment increases Akkermansia in the gut and improves high-fat diet-induced atherosclerosis in Apoe ( Dong, L; Hu, Y; Liu, T; Shen, X; Weng, S; Zhang, D; Zhu, H; Zhu, J; Zhu, L, 2018) |
| "We conclude that berberine reduces oxidative stress and vascular inflammation, and suppresses atherogenesis via a mechanism that includes stimulation of AMPK-dependent UCP2 expression." | 7.77 | Activation of AMP-activated protein kinase is required for berberine-induced reduction of atherosclerosis in mice: the role of uncoupling protein 2. ( Liang, B; Shirwany, N; Wang, Q; Zhang, M; Zhu, Y; Zou, MH, 2011) |
| "Diabetic atherosclerosis is characterized by hyperglycemia, hyperinsulinemia, and dyslipidemia." | 5.72 | Berberine attenuates diabetic atherosclerosis via enhancing the interplay between KLF16 and PPARα in ApoE ( Hu, C; Ma, C; Man, B; Xiang, J; Yang, G; Yang, S, 2022) |
| "This study aims to analyze the effect of berberine on serum inflammatory factors and carotid atherosclerotic plaques in ppatients with acute cerebral ischemic stroke(AIS)." | 5.22 | [Effects of berberine on serum inflammatory factors and carotid atherosclerotic plaques in patients with acute cerebral ischemic stroke]. ( Chai, MJ; Li, HS; Li, Y; Lu, DD; Wang, H; Wang, P; Yang, F; Zhao, J, 2016) |
| "Berberine (BBR) is an effective component of Huanglian and has shown to attenuate atherosclerosis (AS); however, the detailed mechanism of BBR-mediated protective actions against AS remains elusive." | 3.96 | Berberine Attenuates Arterial Plaque Formation in Atherosclerotic Rats with Damp-Heat Syndrome via Regulating Autophagy. ( Huang, Y; Ke, X; Li, L; Lin, F; Song, Y; Xin, F; Xu, L; Zeng, Z; Zhang, Y, 2020) |
| " Berberine is used to treat obesity, diabetes and atherosclerosis." | 3.88 | Berberine treatment increases Akkermansia in the gut and improves high-fat diet-induced atherosclerosis in Apoe ( Dong, L; Hu, Y; Liu, T; Shen, X; Weng, S; Zhang, D; Zhu, H; Zhu, J; Zhu, L, 2018) |
| "Berberine increases atherosclerotic plaque stability in hyperhomocysteinemia mice, which is related to the activation of peroxisome proliferator-activated receptor-γ and subsequent suppression of oxidative stress in endothelial cells." | 3.83 | Berberine activates peroxisome proliferator-activated receptor gamma to increase atherosclerotic plaque stability in Apoe ( Fang, L; He, C; Li, H; Li, X; Liu, N; Sun, X; Wang, J; Yang, Z, 2016) |
| "We conclude that berberine reduces oxidative stress and vascular inflammation, and suppresses atherogenesis via a mechanism that includes stimulation of AMPK-dependent UCP2 expression." | 3.77 | Activation of AMP-activated protein kinase is required for berberine-induced reduction of atherosclerosis in mice: the role of uncoupling protein 2. ( Liang, B; Shirwany, N; Wang, Q; Zhang, M; Zhu, Y; Zou, MH, 2011) |
| "Diabetic atherosclerosis is characterized by hyperglycemia, hyperinsulinemia, and dyslipidemia." | 1.72 | Berberine attenuates diabetic atherosclerosis via enhancing the interplay between KLF16 and PPARα in ApoE ( Hu, C; Ma, C; Man, B; Xiang, J; Yang, G; Yang, S, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Man, B | 1 |
| Hu, C | 1 |
| Yang, G | 1 |
| Xiang, J | 1 |
| Yang, S | 1 |
| Ma, C | 1 |
| Ke, X | 1 |
| Huang, Y | 1 |
| Li, L | 1 |
| Xin, F | 1 |
| Xu, L | 1 |
| Zhang, Y | 2 |
| Zeng, Z | 1 |
| Lin, F | 1 |
| Song, Y | 1 |
| Li, Y | 1 |
| Wang, P | 1 |
| Chai, MJ | 1 |
| Yang, F | 1 |
| Li, HS | 1 |
| Zhao, J | 1 |
| Wang, H | 1 |
| Lu, DD | 1 |
| Zhu, L | 1 |
| Zhang, D | 1 |
| Zhu, H | 1 |
| Zhu, J | 1 |
| Weng, S | 1 |
| Dong, L | 1 |
| Liu, T | 1 |
| Hu, Y | 1 |
| Shen, X | 1 |
| Geng, C | 1 |
| Hidru, TH | 1 |
| Zhi, L | 1 |
| Tao, M | 1 |
| Zou, L | 1 |
| Chen, C | 1 |
| Li, H | 2 |
| Liu, Y | 1 |
| He, C | 1 |
| Wang, J | 1 |
| Li, X | 1 |
| Yang, Z | 1 |
| Sun, X | 1 |
| Fang, L | 1 |
| Liu, N | 1 |
| Wang, Q | 1 |
| Zhang, M | 1 |
| Liang, B | 1 |
| Shirwany, N | 1 |
| Zhu, Y | 1 |
| Zou, MH | 1 |
1 review available for berberine and Atheroma
| Article | Year |
|---|---|
Sonodynamic therapy: A potential treatment for atherosclerosis.
Topics: Animals; Anthracenes; Antineoplastic Agents; Apoptosis; Atherosclerosis; Berberine; Cell Death; Chal | 2018 |
1 trial available for berberine and Atheroma
| Article | Year |
|---|---|
[Effects of berberine on serum inflammatory factors and carotid atherosclerotic plaques in patients with acute cerebral ischemic stroke].
Topics: Anti-Inflammatory Agents; Berberine; Brain Ischemia; Carotid Intima-Media Thickness; Humans; Interle | 2016 |
5 other studies available for berberine and Atheroma
| Article | Year |
|---|---|
Berberine attenuates diabetic atherosclerosis via enhancing the interplay between KLF16 and PPARα in ApoE
Topics: Animals; Apolipoproteins E; Atherosclerosis; Berberine; Diabetes Mellitus; Glucose; Inflammation; Kr | 2022 |
Berberine Attenuates Arterial Plaque Formation in Atherosclerotic Rats with Damp-Heat Syndrome via Regulating Autophagy.
Topics: Administration, Oral; Animals; Atherosclerosis; Autophagy; Berberine; Disease Models, Animal; Dose-R | 2020 |
Berberine treatment increases Akkermansia in the gut and improves high-fat diet-induced atherosclerosis in Apoe
Topics: Animals; Anti-Inflammatory Agents; Aorta; Aortic Diseases; Atherosclerosis; Berberine; Cytokines; Di | 2018 |
Berberine activates peroxisome proliferator-activated receptor gamma to increase atherosclerotic plaque stability in Apoe
Topics: Animals; Apolipoproteins E; Berberine; Carotid Arteries; Cell Survival; Cells, Cultured; Disease Mod | 2016 |
Activation of AMP-activated protein kinase is required for berberine-induced reduction of atherosclerosis in mice: the role of uncoupling protein 2.
Topics: Acetyl-CoA Carboxylase; Aldehydes; AMP-Activated Protein Kinases; Animals; Aorta; Apolipoproteins E; | 2011 |